Effects of trial characteristics on CONSORT score
| Variable | Mean score (SD) | p Value |
|---|---|---|
| Treatment duration | ||
| <12 m (n=21) | 53.1% (17.8%) | NS |
| ≥12 m (n=12) | 59.4% (16.1%) | |
| Participant number | ||
| <100 (n=16) | 46.5% (13.5%) | 0.011 |
| ≥100 (n=17) | 63.7% (16.4%) | |
| Primary end point result | ||
| Positive | 57.5% (19.6%) | NS |
| Negative | 52.7% (15.5%) | |
| Centres | ||
| Single centre (n=14) | 48.0% (14.0%) | NS |
| Multicentre (n=10) | 57.3% (19.0%) | |
| International multicentre (n=9) | 64.8% (16.2%) | |
| Assignment | ||
| Parallel (n=5) | 49.1% (20.1%) | NS |
| Crossover (n=28) | 56.5% (16.8%) | |
| Funding/sponsor | ||
| National, charity, academic (n=18) | 56.5% (15.4%) | NS |
| Pharmaceutical company, industry (n=15) | 59.2% (17.0%) | |